11 results on '"Hegyi, P.J."'
Search Results
2. Study of the early phase of chronic pancreatitis: Results of a 2-year follow-up of the first 133 patients in the GOULASH-PLUS study
- Author
-
Mikó, A., primary, Kató, D., additional, Lillik, V., additional, Váncsa, S., additional, Hegyi, P.J., additional, Sarlós, P., additional, Vincze, Á., additional, Faluhelyi, N., additional, Bódis, B., additional, Gajdán, L., additional, Izbéki, F., additional, and Hegyi, P., additional
- Published
- 2021
- Full Text
- View/download PDF
3. Alcohol consumption and smoking are dose dependently worsen the outcome of acute pancreatitis
- Author
-
Szentesi, A., primary, Gede, N., additional, Foldi, M., additional, Kiss, S., additional, Gyomber, Z., additional, Vincze, A., additional, Godi, S., additional, Bajor, J., additional, Nemeth, B.C., additional, Takacs, T., additional, Czako, L., additional, Izbeki, F., additional, Hamvas, J., additional, Varga, M., additional, Sallinen, V., additional, Macarie, M., additional, Torok, I., additional, Mickevicius, A., additional, Maldonado, E. Ramirez, additional, Miseta, A., additional, Nagy, T., additional, Faluhelyi, N., additional, Kanizsai, P., additional, Pecsi, D., additional, Varju, P., additional, Zadori, N., additional, Hegyi, P.J., additional, Parniczky, A., additional, and Hegyi, P., additional
- Published
- 2021
- Full Text
- View/download PDF
4. Safe and effective protocol to discharge patients in acute pancreatitis
- Author
-
Nagy, R., primary, Hanák, L., additional, Ocskay, K., additional, Mikó, A., additional, Hegyi, P.J., additional, Farkas, N., additional, Németh, D., additional, Szentesi, A., additional, Párniczky, A., additional, and Hegyi, P., additional
- Published
- 2021
- Full Text
- View/download PDF
5. Early occurrence of pseudocysts in acute pancreatitis – a multicenter international cohort analysis of 2275 acute pancreatitis cases
- Author
-
Szakó, L., primary, Váradi, A., additional, Tinusz, B., additional, Vörhendi, N., additional, Mosztbacher, D., additional, Vincze, Á., additional, Takács, T., additional, Czakó, L., additional, Izbéki, F., additional, Gajdán, L., additional, Dunás-Varga, V., additional, Hamvas, J., additional, Papp, M., additional, Fehér, K.E., additional, Varga, M., additional, Mickevicius, A., additional, Török, I., additional, Ocskay, K., additional, Juhász, M.F., additional, Váncsa, S., additional, Faluhelyi, N., additional, Farkas, O., additional, Miseta, A., additional, Vereczkei, A., additional, Mikó, A., additional, Hegyi, P.J., additional, Szentesi, A., additional, Párniczky, A., additional, Eross, B., additional, and Hegyi, P., additional
- Published
- 2021
- Full Text
- View/download PDF
6. The role of endoscopic ultrasound (EUS) in the diagnosis and treatment of insulinoma: A systematic review of the literature
- Author
-
El-Sayed, G., primary, Frim, L., additional, Franklin, J., additional, McCrudden, R., additional, Gordon, C., additional, Al-Shamma, S., additional, Kiss, S., additional, Hegyi, P., additional, Eross, B., additional, and Hegyi, P.J., additional
- Published
- 2021
- Full Text
- View/download PDF
7. The characteristics and prognostic role of acute abdominal on-admission pain in acute pancreatitis: A prospective cohort-analysis of 1432 cases
- Author
-
Földi, M., primary, Gede, N., additional, Kiss, S., additional, Vincze, Á., additional, Bajor, J., additional, Szabó, I., additional, Szepes, Z., additional, Izbéki, F., additional, Gervain, J., additional, Hamvas, J., additional, Vitális, Z., additional, Fehér, E., additional, Crai, S., additional, Sallinen, V., additional, Moldando, E. Ramirez, additional, Meczker, Á., additional, Varjú, P., additional, Poropat, G., additional, Stimac, D., additional, Faluhegyi, N., additional, Miseta, A., additional, Nagy, T., additional, Vereczkei, A., additional, Márton, Z., additional, Hegyi, P.J., additional, Hegyi, P., additional, Párniczky, A., additional, and Szentesi, A., additional
- Published
- 2021
- Full Text
- View/download PDF
8. Risk prediction model for developing pancreatic necrosis
- Author
-
Kiss, S., primary, Farkas, N., additional, Fehérvári, P., additional, Pecze, L., additional, Szakó, L., additional, Vincze, Á., additional, Gódi, S., additional, Bajor, J., additional, Czimmer, J., additional, Sarlós, P., additional, Hágendorn, R., additional, Takács, T., additional, Izbéki, F., additional, Halász, A., additional, Hamvas, J., additional, Varga, M., additional, Crai, S., additional, Mickevicius, A., additional, Patai, Á., additional, Ihász, M., additional, Varjú, P., additional, Faluhelyi, N., additional, Farkas, O., additional, Miseta, A., additional, Kelemen, D., additional, Papp, R., additional, Hegyi, P.J., additional, Szentesi, A., additional, Párniczky, A., additional, and Hegyi, P., additional
- Published
- 2021
- Full Text
- View/download PDF
9. Response to “Drug-induced acute pancreatitis in ulcerative colitis”
- Author
-
Hegyi, P.J., primary and Hegyi, P., additional
- Published
- 2021
- Full Text
- View/download PDF
10. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review.
- Author
-
El Sayed, G., Frim, L., Franklin, James, McCrudden, R., Gordon, C., Al-Shamma, S., Kiss, S., Hegyi, P., Erőss, B., Hegyi, P.J., El Sayed, G., Frim, L., Franklin, James, McCrudden, R., Gordon, C., Al-Shamma, S., Kiss, S., Hegyi, P., Erőss, B., and Hegyi, P.J.
- Abstract
Background: Insulinoma is the most common neuroendocrine neoplasm of the pancreas, characterised by hypoglycaemic symptoms. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and ethanol ablation (EUS-EA) are novel methods for treating insulinoma.We aimed to perform a systematic review to assess the efficacy and safety of EUS-guided ablation techniques for pancreatic insulinomas. Methods: We systematically searched for articles detailing EUS-guided ablations of insulinomas. We performed a qualitative analysis and summarised data on the efficacy and safety of EUS-RFA and EUS-EA techniques. Results: In total, we identified 35 case reports and case series describing 75 patients with insulinomas treatment with EUS-guided ablation. Twenty-seven patients were treated with EUS-RFA, 47 patients with EUS-EA, and 1 patient received EUS-EA and EUS-RFA in the same session. In total, 84 insulinomas were ablated (EUS-RFA: 31, EUS-EA: 53). Most insulinomas were in the head of the pancreas (40%). The clinical success rate for EUS-guided ablation techniques was 98.5%. The median glucose level was 1.95 (Q1-Q3: 1.69-2.13) mmol/L before ablation compared to 6.20 (Q1-Q3: 5.30-7.05) mmol/L after treatment. The median insulin and C-peptide levels before and after RFA/EA were 230 (Q1-Q2: 120-257) pmol/L and 41 (Q1-Q2 35-42) pmol/L; 2077 (Q1-Q2 1644-2459) pmol/L and 819 (Q1-Q2 696-1072) pmol/L, respectively. There were eleven adverse events: seven abdominal pain, two mild acute pancreatitis, one necrotising acute pancreatitis and one local hematoma. All patients recovered, and there were no periprocedural deaths. Conclusions: EUS-guided ablation of insulinoma seems to be a safe and effective treatment and is an alternative to surgical resection in selected cases.
11. Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis - An international cohort study
- Author
-
Péter Jenő Hegyi, Áron Vincze, Alexandra Demcsák, László Gajdán, Andrey Litvin, Andra Iulia Suceveanu, Eva Pijoan Comas, Riccardo Casadei, George I Papachristou, Vincenzo Cennamo, Yu-Ting Chang, Péter Hegyi, Ionut Negoi, Carlo Ingaldi, Vitor Nunes, Adriano Quiroga Castiñeira, Lihui Deng, Orestis Ioannidis, Ernő Bóna, Milene Raquel Ramos Moreira e Sá, Juan Armando Rodriguez-Oballe, Andrea Jardi Cuadrado, József Hamvas, Judit Bajor, Alexander Schneider, Tiago Cúrdia Gonçalves, Haluk Tarik Kani, Alexandra Soós, Serge Chooklin, Marcus Hollenbach, Claudio Ricci, Marta Freitas, Isabel Miguel Salas, Michael Hirth, Cristina Tocia, Dóra Illés, Daniel de la Iglesia Garcia, Amir Gougol, Patrícia Sarlós, Marco Marino, Emőke Miklós, Qing Xia, Valentina Negoita, Mihailo Bezmarevic, Radislav Nakov, Erika Darvasi, Deniz Güney Duman, Péter Kanizsai, Laura Mastrangelo, Vasile Sandru, Andrea Párniczky, Hubert Zatorski, Andrea Szentesi, Mária Papp, Mario Pelaez-Luna, Marcel Tantau, Yliya Rabotyagova, Ferenc Izbéki, Natalia V Shirinskaya, Cristian Gheorghe, Ewa Małecka-Panas, Giedrius Barauskas, Engin Altintaş, Wei Huang, Ali Kchaou, Povilas Ignatavicius, Cezar Ciubotaru, Stefania Bunduc, Jorge Paulino Pereira, Dong Wu, Sabite Kacar, Alina Tantau, António Pedro Gomes, Svetlana Turcan, Bálint Erőss, Sorin T. Barbu, Adriana Gherbon, Georgi Minkov, Júlio Constantino, Márk Félix Juhász, Jimin Han, Serhii Chuklin, Klementina Ocskay, Mila Kovacheva-Slavova, Eugen Tcaciuc, Elio Jovine, Lilla Barbara Kincses, Ines Capunge, Gabriel Constantinescu, Bogdan Mateescu, Eugen Dumitru, Ming-Chu Chang, Andrea Soriano Rios, Márta Varga, László Czakó, Volkan Gökbulut, Alexandra Mikó, Szilárd Váncsa, Ahmed Tlili, Demcsak, Alexandra, Soos, Alexandra, Kincses, Lilla, Capunge, Ines, Minkov, Georgi, Kovacheva-Slavova, Mila, Nakov, Radislav, Wu, Dong, Huang, Wei, Xia, Qing, Deng, Lihui, Hollenbach, Marcus, Schneider, Alexander, Hirth, Michael, Ioannidis, Orestis, Vincze, Aron, Bajor, Judit, Sarlos, Patricia, Czako, Laszlo, Illes, Dora, Izbeki, Ferenc, Gajdan, Laszlo, Papp, Maria, Hamvas, Jozsef, Varga, Marta, Kanizsai, Peter, Bona, Erno, Miko, Alexandra, Vancsa, Szilard, Juhasz, Mark Felix, Ocskay, Klementina, Darvasi, Erika, Miklos, Emoke, Eross, Balint, Szentesi, Andrea, Parniczky, Andrea, Casadei, Riccardo, Ricci, Claudio, Ingaldi, Carlo, Mastrangelo, Laura, Jovine, Elio, Cennamo, Vincenzo, Marino, Marco V., Barauskas, Giedrius, Ignatavicius, Povilas, Pelaez-Luna, Mario, Rios, Andrea Soriano, Turcan, Svetlana, Tcaciuc, Eugen, Malecka-Panas, Ewa, Zatorski, Hubert, Nunes, Vitor, Gomes, Antonio, Goncalves, Tiago Curdia, Freitas, Marta, Constantino, Julio, Sa, Milene, Pereira, Jorge, Mateescu, Bogdan, Constantinescu, Gabriel, Sandru, Vasile, Negoi, Ionut, Ciubotaru, Cezar, Negoita, Valentina, Bunduc, Stefania, Gheorghe, Cristian, Barbu, Sorin, Tantau, Alina, Tantau, Marcel, Dumitru, Eugen, Suceveanu, Andra Iulia, Tocia, Cristina, Gherbon, Adriana, Litvin, Andrey, Shirinskaya, Natalia, Rabotyagova, Yliya, Bezmarevic, Mihailo, Hegyi, Peter Jeno, Han, Jimin, Rodriguez-Oballe, Juan Armando, Salas, Isabel Miguel, Comas, Eva Pijoan, de la Iglesia Garcia, Daniel, Cuadrado, Andrea Jardi, Castineira, Adriano Quiroga, Chang, Yu-Ting, Chang, Ming-Chu, Kchaou, Ali, Tlili, Ahmed, Kacar, Sabite, Gokbulut, Volkan, Duman, Deniz, Kani, Haluk Tarik, Altintas, Engin, Chooklin, Serge, Chuklin, Serhii, Gougol, Amir, Papachristou, George, Hegyi, Peter, Demcsak A., Soos A., Kincses L., Capunge I., Minkov G., Kovacheva-Slavova M., Nakov R., Wu D., Huang W., Xia Q., Deng L., Hollenbach M., Schneider A., Hirth M., Ioannidis O., Vincze A., Bajor J., Sarlos P., Czako L., Illes D., Izbeki F., Gajdan L., Papp M., Hamvas J., Varga M., Kanizsai P., Bona E., Miko A., Vancsa S., Juhasz M.F., Ocskay K., Darvasi E., Miklos E., Eross B., Szentesi A., Parniczky A., Casadei R., Ricci C., Ingaldi C., Mastrangelo L., Jovine E., Cennamo V., Marino M.V., Barauskas G., Ignatavicius P., Pelaez-Luna M., Rios A.S., Turcan S., Tcaciuc E., Malecka-Panas E., Zatorski H., Nunes V., Gomes A., Goncalves T.C., Freitas M., Constantino J., Sa M., Pereira J., Mateescu B., Constantinescu G., Sandru V., Negoi I., Ciubotaru C., Negoita V., Bunduc S., Gheorghe C., Barbu S., Tantau A., Tantau M., Dumitru E., Suceveanu A.I., Tocia C., Gherbon A., Litvin A., Shirinskaya N., Rabotyagova Y., Bezmarevic M., Hegyi P.J., Han J., Rodriguez-Oballe J.A., Salas I.M., Comas E.P., Garcia D.D.L.I., Cuadrado A.J., Castineira A.Q., Chang Y.-T., Chang M.-C., Kchaou A., Tlili A., Kacar S., Gokbulut V., Duman D., Kani H.T., Altintas E., Chooklin S., Chuklin S., Gougol A., Papachristou G., and Hegyi P.
- Subjects
Male ,Endocrinology, Diabetes and Metabolism ,Gastroenterology ,Cohort Studies ,Feces ,0302 clinical medicine ,Risk Factors ,Surveys and Questionnaires ,Acid suppressing drug ,Acute pancreatitis ,Gastrointestinal bleeding ,Gastrointestinal infection ,Proton pump inhibitor ,Enterocolitis, Pseudomembranous ,Aged, 80 and over ,RISK ,ASSOCIATION ,Middle Aged ,Clostridium difficile ,CANCER ,3. Good health ,Hospitalization ,Treatment Outcome ,030220 oncology & carcinogenesis ,Acute Disease ,Female ,030211 gastroenterology & hepatology ,Gastrointestinal Hemorrhage ,Cohort study ,Adult ,medicine.medical_specialty ,GI bleeding ,medicine.drug_class ,Proton-pump inhibitor ,Infections ,PROTON-PUMP INHIBITORS ,03 medical and health sciences ,Internal medicine ,mental disorders ,medicine ,MANAGEMENT ,Humans ,DRUGS ,Acute pancreatiti ,Aged ,Retrospective Studies ,Hepatology ,Clostridioides difficile ,business.industry ,Proton Pump Inhibitors ,medicine.disease ,Pancreatitis ,Acid suppression ,business - Abstract
Background: Acid suppressing drugs (ASD) are generally used in acute pancreatitis (AP); however, large cohorts are not available to understand their efficiency and safety. Therefore, our aims were to evaluate the association between the administration of ASDs, the outcome of AP, the frequency of gastrointestinal (GI) bleeding and GI infection in patients with AP. Methods: We initiated an international survey and performed retrospective data analysis on AP patients hospitalized between January 2013 and December 2018. Results: Data of 17,422 adult patients with AP were collected from 59 centers of 23 countries. We found that 23.3% of patients received ASDs before and 86.6% during the course of AP. ASDs were prescribed to 57.6% of patients at discharge. ASD administration was associated with more severe AP and higher mortality. GI bleeding was reported in 4.7% of patients, and it was associated with pancreatitis severity, mortality and ASD therapy. Stool culture test was performed in 6.3% of the patients with 28.4% positive results. Clostridium difficile was the cause of GI infection in 60.5% of cases. Among the patients with GI infections, 28.9% received ASDs, whereas 24.1% were without any acid suppression treatment. GI infection was associated with more severe pancreatitis and higher mortality. Conclusions: Although ASD therapy is widely used, it is unlikely to have beneficial effects either on the outcome of AP or on the prevention of GI bleeding during AP. Therefore, ASD therapy should be substantially decreased in the therapeutic management of AP. (C) 2020 IAP and EPC. Published by Elsevier B.V.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.